Radiofrequency ablation for pediatric recurrent hepatocellular carcinoma: a single-center experience

Radiofrequency ablation for pediatric recurrent hepatocellular carcinoma: a single-center experience

Abstract Purpose To summarize our single-center experience with percutaneous ultrasound (US)-guided radiofrequency ablation (RFA) for pediatric recurrent hepatocellular carcinoma (RHCC). Methods From September 2007 to September 2021, patients under 18 who underwent percutaneous US-guided RFA for RHC...

Full description

Bibliographic Details
Main Authors:	Haiyi Long, Wenxin Wu, Luyao Zhou, Hui Shen, Xiaoyan Xie, Baoxian Liu
Format:	Article
Language:	English
Published:	BMC 2023-12-01
Series:	BMC Medical Imaging
Subjects:	Radiofrequency ablation Recurrent hepatocellular carcinoma Children Safety Local tumor progression Survival
Online Access:	https://doi.org/10.1186/s12880-023-01159-3

Similar Items

Feasibility and outcomes of percutaneous radiofrequency ablation for intrahepatic recurrent hepatocellular carcinoma after liver transplantation: a single-center experience
by: Baoxian Liu, et al.
Published: (2020-01-01)

Ablative Volume of Radiofrequency Ablation Related to Intrahepatic Recurrence-Free Survival of Hepatocellular Carcinoma
by: Nakarin Inmutto, et al.
Published: (2021-07-01)

Feeding artery ablation before radiofrequency ablation for hepatocellular carcinoma may reduce critical recurrence
by: Ryo Shimizu, et al.
Published: (2021-04-01)

Aggressive tumor recurrence after radiofrequency ablation for hepatocellular carcinoma
by: Tae Wook Kang, et al.
Published: (2017-03-01)

Risk Factors, Patterns, and Long-Term Survival of Recurrence After Radiofrequency Ablation With or Without Transarterial Chemoembolization for Hepatocellular Carcinoma
by: Jingjun Huang, et al.
Published: (2021-05-01)

Treatment optimization for recurrent hepatocellular carcinoma: Repeat hepatic resection versus radiofrequency ablation
by: Liang‐He Lu, et al.
Published: (2020-05-01)

Long-term survival of hepatocellular carcinoma after percutaneous radiofrequency ablation guided by ultrasound
by: Weimin Zhang, et al.
Published: (2017-07-01)

Radiofrequency ablation with or without transarterial chemoembolization for hepatocellular carcinoma meeting Milan criteria: a focus on tumor progression and recurrence patterns
by: Yong Xie, et al.
Published: (2024-05-01)

Radiofrequency ablation versus hepatic resection for recurrent hepatocellular carcinoma: an updated meta-analysis
by: Daopeng Yang, et al.
Published: (2020-11-01)

Laparoscopic radiofrequency ablation versus percutaneous radiofrequency ablation for subphrenic hepatocellular carcinoma
by: Min Hwan Kwak, et al.
Published: (2022-07-01)

Radiofrequency ablation in the treatment of hepatocellular carcinoma
by: Qingsong Deng, et al.
Published: (2022-12-01)

Laparoscopic hepatectomy versus radiofrequency ablation in treatment of recurrent hepatocellular carcinoma: a prospective randomized control study based on interim follow-up analysis
by: LIU Jialong, et al.
Published: (2019-03-01)

Preoperative prognostic value of alfa-fetoprotein density in patients with hepatocellular carcinoma undergoing radiofrequency ablation
by: Bo-Wen Zhuang, et al.
Published: (2022-12-01)

Percutaneous radiofrequency ablation of adrenal metastases from hepatocellular carcinoma: a single-center experience
by: Jingzhi Huang, et al.
Published: (2019-06-01)

Recurrence after percutaneous radiofrequency ablation of hepatocellular carcinoma: Analysis of the pattern and risk factors
by: Rui Chen, et al.
Published: (2023-02-01)

Radiofrequency ablation plays double role in immunosuppression and activation of PBMCs in recurrent hepatocellular carcinoma
by: Yang Zhao, et al.
Published: (2024-01-01)

Long‐term efficacy of no‐touch radiofrequency ablation in the treatment of single small hepatocellular carcinoma: A single center long‐term follow‐up study
by: Guodong Wu, et al.
Published: (2023-03-01)

Long-term outcomes of combined radiofrequency ablation and multipronged ethanol ablation for the treatment of unfavorable hepatocellular carcinoma
by: Ming Liu, et al.
Published: (2023-03-01)

Microwave ablation is as effective as radiofrequency ablation for very-early-stage hepatocellular carcinoma
by: Yun Xu, et al.
Published: (2017-01-01)

Radiofrequency ablation combined with toripalimab for recurrent hepatocellular carcinoma: A prospective controlled trial
by: Zhenyu Wen, et al.
Published: (2023-10-01)

Liver resection versus radiofrequency ablation for recurrent hepatocellular carcinoma: a systematic review and meta-analysis
by: Yao Yang, et al.
Published: (2021-01-01)

Surgery versus radiofrequency ablation in patients with Child- Pugh class-A/single small (≤3 cm) hepatocellular carcinoma
by: Jungnam Lee, et al.
Published: (2022-04-01)

Clinical significance and predictive factors of early massive recurrence after radiofrequency ablation in patients with a single small hepatocellular carcinoma
by: Ju-Yeon Cho, et al.
Published: (2016-12-01)

Suppression of popping rates in radiofrequency ablation under perfluorobutane microbubbles for hepatocellular carcinoma
by: Toru Ishikawa, et al.
Published: (2024-12-01)

Switching Monopolar No-Touch Radiofrequency Ablation Using Octopus Electrodes for Small Hepatocellular Carcinoma: A Randomized Clinical Trial
by: Sae-Jin Park, et al.
Published: (2020-12-01)

Progression of hepatocellular carcinoma after radiofrequency ablation: Current status of research
by: Shilun Wu, et al.
Published: (2022-11-01)

Albumin-to-alkaline phosphatase ratio as a predictor of tumor recurrence and prognosis in patients with early-stage hepatocellular carcinoma undergoing radiofrequency ablation as initial therapy
by: Feng Zhang, et al.
Published: (2021-01-01)

Radiofrequency ablation compared with repeat hepatectomy for patients with recurrent hepatocellular carcinoma: A meta-analysis
by: Yi-gang Zhang, et al.
Published: (2022-12-01)

A systematic review and meta-analysis of the comparison of laparoscopic radiofrequency ablation to percutaneous radiofrequency ablation for hepatocellular carcinoma
by: Ya-Qiong Wang, et al.
Published: (2025-03-01)

Percutaneous radiofrequency ablation of tumor feeding artery before target tumor ablation may reduce local tumor progression in hepatocellular carcinoma
by: Ya-Ting Cheng, et al.
Published: (2016-12-01)

Using the aMAP Risk Score to Predict Late Recurrence Following Radiofrequency Ablation for Hepatocellular Carcinoma in Chinese Population: A Multicenter Study
by: Yang Y, et al.
Published: (2021-07-01)

Combined resection and radiofrequency ablation versus transarterial embolization for intermediate-stage hepatocellular carcinoma: A propensity score matching study
by: Wendell Espinosa, et al.
Published: (2018-03-01)

Adjuvant Sorafenib Following Radiofrequency Ablation for Early-Stage Recurrent Hepatocellular Carcinoma With Microvascular Invasion at the Initial Hepatectomy
by: Meng-Chao Wei, et al.
Published: (2022-06-01)

Sequential transarterial chemoembolization and early radiofrequency ablation improves clinical outcomes for early-intermediate hepatocellular carcinoma in a 10-year single-center comparative study
by: Liangliang Yan, et al.
Published: (2021-04-01)

Pulmonary Metastasectomy after Radiofrequency Ablation of Hepatocellular Carcinoma
by: Takahiro Osuga, et al.
Published: (2024-03-01)

Recent technical advances in radiofrequency ablations for hepatocellular carcinoma
by: Dong Ho Lee
Published: (2021-10-01)

Surgical resection versus ablation for early hepatocellular carcinoma: The debate is still open
by: Bo Hyun Kim
Published: (2022-04-01)

Liver resection, radiofrequency ablation, and radiofrequency ablation combined with transcatheter arterial chemoembolization for very-early- and early-stage hepatocellular carcinoma: A systematic review and Bayesian network meta-analysis for comparison of efficacy
by: Yunlong Zhang, et al.
Published: (2022-10-01)

Adjuvant sorafenib for hepatocellular carcinoma after radiofrequency ablation versus radiofrequency ablation: analysis of its efficacy and safety
by: Wang Junxiao, et al.
Published: (2024-12-01)

Single-session combined radiofrequency ablation and transarterial chemoembolization in the treatment of hepatocellular carcinoma
by: Mahmoud A. Dawoud, et al.
Published: (2017-12-01)